[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Liu H, Guo H, Jian Z, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L
Cyclic Heptapeptide Lactam-Bridged Macrocycle -MSH Analogue Reported Pharmacology (Literature, Neutral) Reported Melanocortin receptor agonism Non-selective MC1R / MC3R / MC4R / MC5R agonist Molinoff and colleagues (Ann N Y Acad Sci 2003) reported: PT-141, a synthetic peptide analogue of alpha-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R, which are expressed primarily in the central nervous system. Reported as a neutral pharmacology statement in the academic record
No, compounded semaglutide contains the same active ingredient as FDA-approved GLP-1 medications but is prepared by a licensed 503B compounding pharmacy
Cardiac protection: Unlike BPC-157's gastric origins, TB-500 has been studied particularly for cardiac applications, showing potential for heart tissue repair
Pharmacology Research & Perspectives, 10 (4)
Gallagher, S